Skip to main content
SpringerLink
Log in

The measurement of norepinephrine clearance and spillover rate into plasma in conscious spontaneously hypertensive rats

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The clearance of norepinephrine from plasma and the spillover rate of norepinephrine into plasma were determined in conscious unrestrained spontaneously hypertensive rats by measuring the concentrations of 3H-norepinephrine and norepinephrine in arterial plasma after 90 min of i. v. infusion with 3H-norepinephrine. In 50 conscious spontaneously hypertensive rats treated with saline (control animals), the following basal values were obtained: plasma norepinephrine concentration = 149 ± 5 pg/ml; plasma epinephrine concentration = 61 ± 4 pg/ml; norepinephrine clearance = 188 ± 4 ml min-1 kg-1; and norepinephrine spillover rate = 27.5 ± 0.8 ng min-1 kg−1. A significant portion of infused 3H-norepinephrine appeared to be cleared from the plasma by the uptake, process, since desipramine decreased norepinephrine clearance by 32%. The vasodilating agents hydralazine and minoxidil produced dose-related increases in norepinephrine spillover rate and plasma norepinephrine concentration, but the percent increases in norepinephrine spillover rate exceeded the percent increases in plasma norepinephrine concentration because of concomitant increases in norepinephrine clearance, particularly after treatment with minoxidil. The increase in norepinephrine clearance caused by hydralazine and minoxidil probably resulted from the increase in cardiac output and resultant increase in hepatic and/or pulmonary blood flow. Adrenal secretion of norepinephrine did not appear to contribute to the elevation in norepinephrine spillover rate elicited by hydralazine and minoxidil. Chlorisondamine suppressed norepinephrine spillover rate by 77%, in association with a 70% decline in plasma epinephrine concentration, whereas bretylium lowered norepinephrine spillover rate by only 41%, with no change in plasma epinephrine concentration. The decrements in norepinephrine clearance caused by chlorisondamine (−23%) and bretylium (−15%) were more or less proportional to the magnitude of the vasodepression caused by these drugs. Both norepinephrine spillover rate and clearance fell in a dose-related fashion after treatment with clonidine. After treatment with the sympathoinhibitory agents chlorisondamine, bretylium and clonidine, the percent decreases in norepinephrine spillover rate always exceeded the percent decreases in plasma norepinephrine concentration. Based on these observations, we conclude that norepinephrine spillover rate provides a more accurate measurement of the activity of the peripheral sympathetic nervous system than does plasma norepinephrine concentration in conscious spontaneously hypertensive rats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Benedict CR, Fillenz M, Stanford C (1978) Changes in plasma noradrenaline concentration as a measure of release rate. Br J Pharmacol 64:305–309

    Google Scholar 

  • Best JD, Halter JB (1985) Blood pressure and norepinephrine spillover during propranolol infusion in humans. Am J Physiol 248:R400-R406

    Google Scholar 

  • Best JD, Taborsky GJ Jr, Flatness DE, Halter JB (1984) Effect of pentobarbital anesthesia on plasma norepinephrine kinetics in dogs. Endocrinology 115:853–857

    Google Scholar 

  • Bolt GR, Saxena PR (1984) Interaction of atenolol with systemic and regional hemodynamic effects of hydralazine in conscious renal hypertensive rabbits. J Pharmacol Exp Ther 230:205–213

    Google Scholar 

  • Bouvier M, de Champlain J (1985) Increased apparent norepinephrine release rate in anesthetized DOCA-salt hypertensive rats. Clin Exp Hypertension A7:1629–1645

    Google Scholar 

  • Bravo EL, Tarazi RC (1982) Plasma catecholamines in clinical investigation: a useful index or meaningless number? J Lab Clin Med 100:155–160

    Google Scholar 

  • Ester M (1982) Assessment of sympathetic function in humans from noradrenaline plasma kinetics. Clin Sci 62:247–254

    Google Scholar 

  • Esler M, Jackman G, Bobik A, Kelleher D, Jennings G, Leonard P, Skews H, Korner P (1979) Determination of norepinephrine apparent release rate and clearance in humans. Life Sci 25:1461–1470

    Google Scholar 

  • Ester M, Jackman G, Leonard P, Skews H, Bobik A, Kerner P (1981) Effect of norepinephrine uptake blockers on norepinephrine kinetics. Clin Pharmacol Ther 29:12–20

    Google Scholar 

  • Esler M, Leonard P, O'Dea K, Jackman G, Jennings G, Korner P (1982) Biochemical quantification of sympathetic nervous activity in humans using radiotracer methodology: fallibility of plasma noradrenaline measurements. J Cardiovasc Pharmacol 4:S152-S157

    Google Scholar 

  • Ester M, Jennings G, Korner P, Blombery P, Sacharias N, Leonard P (1984a) Measurement of total and organ-specific norepinephrine kinetics in humans. Am J Physiol 247:E21-E28

    Google Scholar 

  • Esler M, Willett I, Leonard P, Hasking G, Johns J, Little P, Jennings G (1984b) Plasma noradrenaline kinetics in humans. J Autonomic Nervous Sys 11:125–144

    Google Scholar 

  • Feely J, Wade D, McAllister CB, Wilkinson GR, Robertson D (1982) Effect of hypotension on liver blood flow and lidocaine disposition. N Engl J Med 307:866–869

    Google Scholar 

  • Ferrone RA, Walsh GM, Tsuchiya M, Frolich ED (1979) Comparison of hemodynamics in conscious spontaneous and renal hypertensive rats. Am J Physiol 236:H403-H408

    Google Scholar 

  • Garceau D, Yamaguchi N (1982) Pharmacological evidence for the existence of a neuronal amine uptake mechanism in the dog liver. Can J Physiol Pharmacol 60:755–762

    Google Scholar 

  • Goldstein DS, Horowitz D, Keiser HR, Polinsky RJ (1983a) Plasma 1-[3H] norepinephrine, d-[14C]norepinephrine and d,1-[3H] isoproterenol kinetics in essential hypertension. J Clin Invest 72:1748–1758

    Google Scholar 

  • Goldstein DS, McCarty R, Polinsky RJ, Kopin IJ (1983b) Relationship between plasma norepinephrine and sympathetic neural activity. Hypertension 5:552–559

    Google Scholar 

  • Graefe KH, Stefano FJE, Langer SZ (1973) Preferential metabolism of (−)-3H-norepinephrine in the rat vas deferens. Biochem Pharmacol 22:1147–1160

    Google Scholar 

  • Graham RM, Stephenson WH, Pettinger WA (1980) Pharmacological evidence for a functional role of the prejunctional alpha-adrenoceptor in noradrenergic neurotransmission in the conscious rat. Naunyn-Schmiedeberg's Arch Pharmacol 311: 129–138

    Google Scholar 

  • Henriksen JH, Christensen NJ, Ring-Larsen H (1986) Pulmonary extraction of circulating noradrenaline in man. Eur J Clin Invest 16:423–427

    Google Scholar 

  • Hertting G, Axelrod J, Patrick RW (1962) Actions of bretylium and guanethidine on the uptake and release of [3H]-noradrenaline. Br J Pharmacol 18:161–166

    Google Scholar 

  • Hilsted J, Christensen NJ, Madsbad S (1983) Whole body clearance of norepinephrine. The significance of arterial sampling and of surgical stress. J Clin Invest 71:500–505

    Google Scholar 

  • Holtz J, Sommer O, Bassenge E (1987) Inhibition of sympatho-adrenal activity by atrial natriuretic factor in dogs. Hypertension 9:350–354

    Google Scholar 

  • Hubbard JW, Buchholz RA, Keeton TK, Nathan MA (1986) Plasma norepinephrine concentration reflects pharmacological alteration of sympathetic activity in the conscious cat. J Anton Nerv Syst 15:93–100

    Google Scholar 

  • Humphrey SJ, Zins GR (1984) Whole body and regional hemodynamic effects of minoxidil in the conscious dog. J Cardiovasc Pharmacol 6:979–988

    Google Scholar 

  • Johnson MD, Smith PG, Mills E, Schanberg SM (1983) Paradoxical elevation of sympathetic activity during catecholamine infusion in rats. J Pharmacol Exp Ther 227:254–259

    Google Scholar 

  • Jones DH, Allison DJ, Hamilton CA, Reid JL (1979) Selective venous sampling in the diagnosis and localization of phaechromocytoma. Clin Endocrinol 10:179–186

    Google Scholar 

  • Kawashima S, Liang C-S (1985) Systemic and coronary hemodynamic effects of pinacidil, a new antihypertensive agent, in awake dogs: comparison with hydralazine. J Pharmacol Exp Ther 232:369–375

    Google Scholar 

  • Keeton TK, Hall JS, Biediger AM (1987) Response of plasma norepinephrine concentration to the vasodepression caused by β-adrenoceptor antagonists in the conscious spontaneously hypertensive rat. J Cardiovasc Pharmacol 9:356–362

    Google Scholar 

  • Kopin IJ, Zukowska-Grojec Z, Bayorh MA, Goldstein DS (1984) Estimation of intrasynaptic norepinephrine concentrations at vascular neuroeffector junctions in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 325:298–305

    Google Scholar 

  • Luft FC, Veelken R, Becker H, Ganten D, Lang RE, Unger T (1986) Effect of urapidil, clonidine, and prazosin on sympathetic tone in conscious rats. Hypertension 8:303–311

    Google Scholar 

  • Majewski H, Hedler L, Starke K (1982) The noradrenaline release rate in the anaesthetized rabbit: facilitation by adrenaline. Naunyn-Schmiedeberg's Arch Pharmacol 321:20–27

    Google Scholar 

  • Majewski H, Hedler L, Starke K (1983a) Evidence for a physiological role of presynaptic α-adrenoceptors: modulation of noradrenaline released in the pithed rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 324:256–263

    Google Scholar 

  • Majewski H, Hedler L, Starke K (1983b) Modulation of noradrenaline release in the conscious rabbit through α-adrenoceptors. Eur J Pharmacol 93:255–264

    Google Scholar 

  • Majewski H, Rump LC, Hedler L, Starke K (1983c) Effects of α1-and α2-adrenoceptor blocking drugs on noradrenaline release rate in anesthetized rabbits. J Cardiovasc Pharmacol 5:703–711

    Google Scholar 

  • Majewski H, Hedler L, Schurr C, Starke K (1985) Dual effect of adrenaline on noradrenaline release in the pithed rabbit. J Cardiovasc Pharmacol 7:251–257

    Google Scholar 

  • Micalizzi ER, Pals DT (1979) Evaluation of plasma norepinephrine as an index of sympathetic neuron function in the conscious, unrestrained rat. Life Sci 24:2071–2076

    Google Scholar 

  • Peuler JD, Johnson GA (1977) Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci 21:625–636

    Google Scholar 

  • Pratt JH, Yager CJ, Grim CE, Parkinson CA (1980) Increased aldosterone clearance in hypertensive patients treated with minoxidil: An effect of greater hepatic perfusion. J Cardiovasc Pharmacol 63 (Suppl 2):5236–5241

    Google Scholar 

  • Scriabine A (1980) Ganglionic blocking drugs. In: Scriabine A (ed) Pharmacology of antihypertensive drugs. Raven Press, New York, pp 113–117

    Google Scholar 

  • Shah SD, Tse TF, Clutter WE, Cryer PE (1984) The human sympathochromaffin system. Am J Physiol 247:E380-E384

    Google Scholar 

  • Smits JFM, Coleman TG, Smith TL, Kasbergen CM, van Essen H, Struyker-Boudier HAI (1982) Antihypertensive effects of propranolol in conscious spontaneously hypertensive rats: Central hemodynamics, plasma volume, and renal function during β-blockade with propranolol. J Cardiovasc Pharmacol 4:903–914

    Google Scholar 

  • Sole MJ, Drobac M, Schwartz L, Hussain MN, Vaughan-Neil EF (1979) The extraction of circulating catecholamines by the lung in normal man and in patients with pulmonary hypertension. Circ 60:160–163

    Google Scholar 

  • Spokas EG, Wang H-H (1980) Regional blood flow and cardiac response to hydralazine. J Pharmacol Exp Ther 212:294–303

    Google Scholar 

  • Struyker-Boudier HAJ, Van Essen H, Smits JFM (1983) Hemodynamic effects of the arteriolar vasodilators hydralazine, dihydralazine and endralazine in the conscious spontaneously hypertensive rat. Eur J Pharmacol 95:151–159

    Google Scholar 

  • Tarazi RC, Dustan HP, Bravo EL, Niarchos AP (1976) Vasodilating drugs: Contrasting haemodynamic effects. Clin Sci Mol Med 51:575s–578s

  • Togashi H (1983) Central and peripheral effects of clonidine on the adrenal medullary function in spontaneously hypertensive rats. J Pharmacol Exp Ther 225:191–197

    Google Scholar 

  • Veith RC, Best JD, Halter JB (1984) Dose-dependent suppression of norepinephrine appearance rate in plasma by clonidine in man. J Clin Endocrinol Metab 59:151–155

    Google Scholar 

  • Vlachakis ND, Alexander N (1981) Plasma catecholamines and their major metabolites in spontaneously hypertensive rats. Life Sci 29:467–472

    Google Scholar 

  • Wallin BG, Morlin C,Hjemdahl P (1987) Muscle sympathetic activity and venous plasma noradrenaline concentrations during static exercise in normotensive and hypertensive subjects. Acta Physiol Scand 129:489–497

    Google Scholar 

  • Yamaguchi I, Kopin IJ (1979) Plasma catecholamine and blood pressure responses to sympathetic stimulation in pithed rats. Am J Physiol 237:H305-H310

    Google Scholar 

  • Yuki S, Hanazuka M, Watanabe T, Nishi H (1987) Effects of intravenous and intracerebroventricular terazosin, prazosin and clonidine on spontaneous sympathetic outflow in rats. Folia Pharmacol Japon 89:225–233

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Division of Clinical Pharmacology, The University of Texas Health Science Center, 7703 Floyd Curl Drive, 78284, San Antonio, Texas, USA

    T. Kent Keeton & Ana M. Biediger

Authors
  1. T. Kent Keeton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ana M. Biediger
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Send offprint requests to T. K. Keeton at the above address

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kent Keeton, T., Biediger, A.M. The measurement of norepinephrine clearance and spillover rate into plasma in conscious spontaneously hypertensive rats. Naunyn-Schmiedeberg's Arch Pharmacol 338, 350–360 (1988). https://doi.org/10.1007/BF00172109

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00172109

Key words

Search

Navigation